Channels

 

Special Offers & Promotions

 

 

Latest News

 

 

View Channel

New Products

 

 

View Channel

Video Presentations

 

 

View Channel

Separation Science

 

 

View Channel

Microscopy & Image Analysis

 

 

View Channel

Laboratory Automation & IT Solutions

 

 

View Channel

 

?

publication date: Jul 22, 2021
 | 
author/source: Medical Wire & Equipment

mm-inactivation-media

 

Inactivates SARS-CoV-2 in 60 seconds

Designed and manufactured in the UK, Σ–MM™ solution rapidly kills all microorganisms, including bacteria, mycobacteria and viruses, rendering specimens safe for transport, whilst preserving and stabilizing RNA/DNA for accurate molecular analysis across diagnostic platforms.

 

Key Benefits

  • Inactivates SARS-CoV-2 in 60 seconds
  • Rapidly kills all microorganisms, including bacteria, mycobacteria and viruses
  • Suitable for highly infectious clinical specimens
  • DNases and RNases inactivated
  • DNA and RNA preserved for molecular testing
  • Can be used with any swab
  • Powerful reagents kill deadly pathogens quickly
  • Safe and stable for transport at ambient temperature

 

The Σ–MM™ device is a highly effective single step collection.  The medium disturbs and lyses lipid membranes, destroys proteins including DNase and RNase, leaving stable intact DNA or RNA.  Specimens collected into Σ–MM™ can be transported at ambient temperatures, no freezing or refrigeration is required.  Specimens can be collected using any microbiology swabs, including MWE Transwab® and all MWE Dryswab™ products.

Σ–MM™ has been on the market for a number of years and has consistently been shown to effectively eliminate infectious microorganisms from specimens.  During the pandemic, Σ–MM™ has demonstrated compatibility on numerous PCR platforms, where samples were rendered safe for handling & viral RNA was preserved, resulting in accurate diagnostic reporting.

A study was designed in cooperation with the Medical Research Council & University of Glasgow’s Centre for Virus Research to measure the inactivation of SARS-CoV-2 achieved in specimens collected using Σ–MM™.  Σ–MM™ Molecular Medium was tested for the ability to inactivate SARS- CoV-2-Gla-1 isolate.

BS EN 14476 requires that there should be a titre reduction of more than 4 log10 for virucidal suspension tests.  Σ–MM™ consistently exceeded this requirement for both the time points and concentrations used in the study.  In fact, in 1 minute of inoculation there was no detectable virus at all in 6 out of 6 samples tested.  Given that the test concentrations were higher than would be the case for clinical specimens, the study demonstrates that Σ–MM™ can be used as a safe transport system for SARS-CoV-2 specimens, offering rapid inactivation.  The results are consistent with other studies using different inactivation reagents and methods.

 

View Σ–MM™ Product Information

Recent news from MWE

 

 


If you have not logged into the website then please enter your details below.



 

News Channels

 

 

Subscribe to any of our newsletters for the latest on new laboratory products, industry news, case studies and much more!

Newsletters from Lab Bulletin

 

Request your free copies HERE

 

 

 

Popular this Month

Top 10 most popular articles this month

 

 

Today's Picks

 

 

 

 

Looking for a Supplier?

Search by company or by product

 


Company Name:

Product:


 

 

 

 

Please note Lab Bulletin does not sell, supply any of the products featured on this website. If you have an enquiry, please use the contact form below the article or company profile and we will send your request to the supplier so that they can contact you directly.

Lab Bulletin is published by newleaf marketing communications ltd.


 

Media Partners

 

Exhibitions & Events